A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer

Mario E. Lacouture, D. M. Keefe, S. Sonis, A. Jatoi, D. Gernhardt, T. Wang, J. P. Doherty, N. Giri, S. Nadanaciva, J. O'Connell, E. Sbar, B. Piperdi, E. B. Garon

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences